| Mike Yao, MD | |
|
19 Bradhurst Ave Ste 3100n, Hawthorne, NY 10532-2140 | |
| (914) 693-7636 | |
| Not Available |
| Full Name | Mike Yao |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 30 Years |
| Location | 19 Bradhurst Ave Ste 3100n, Hawthorne, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255342267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 261763 (New York) | Secondary |
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | 261763 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westchester Medical Center | Valhalla, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Westchester Medical Center Advanced Physician Services Pc | 3173660776 | 729 |
News Archive
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
In the midst of a national healthcare overhaul, John Rittenhouse, CEO and chairman of Cavallino Consulting, LLC, candidly addresses main issues in the healthcare arena, and offers cures for the operational inefficiencies breaking the current system in his new, accessible guide titled Healthcare, Heal Thyself.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
| Entity Name | Westchester Medical Center Advanced Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912131392 PECOS PAC ID: 3173660776 Enrollment ID: O20091031000042 |
News Archive
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
In the midst of a national healthcare overhaul, John Rittenhouse, CEO and chairman of Cavallino Consulting, LLC, candidly addresses main issues in the healthcare arena, and offers cures for the operational inefficiencies breaking the current system in his new, accessible guide titled Healthcare, Heal Thyself.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275802811 PECOS PAC ID: 2264691070 Enrollment ID: O20120315000035 |
News Archive
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
In the midst of a national healthcare overhaul, John Rittenhouse, CEO and chairman of Cavallino Consulting, LLC, candidly addresses main issues in the healthcare arena, and offers cures for the operational inefficiencies breaking the current system in his new, accessible guide titled Healthcare, Heal Thyself.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609120674 PECOS PAC ID: 8224282926 Enrollment ID: O20130205000439 |
News Archive
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
In the midst of a national healthcare overhaul, John Rittenhouse, CEO and chairman of Cavallino Consulting, LLC, candidly addresses main issues in the healthcare arena, and offers cures for the operational inefficiencies breaking the current system in his new, accessible guide titled Healthcare, Heal Thyself.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770823551 PECOS PAC ID: 2264691070 Enrollment ID: O20131220001018 |
News Archive
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
In the midst of a national healthcare overhaul, John Rittenhouse, CEO and chairman of Cavallino Consulting, LLC, candidly addresses main issues in the healthcare arena, and offers cures for the operational inefficiencies breaking the current system in his new, accessible guide titled Healthcare, Heal Thyself.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mike Yao, MD 19 Bradhurst Ave Ste 3100n, Hawthorne, NY 10532-2140 Ph: (914) 909-9018 | Mike Yao, MD 19 Bradhurst Ave Ste 3100n, Hawthorne, NY 10532-2140 Ph: (914) 693-7636 |
News Archive
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
In the midst of a national healthcare overhaul, John Rittenhouse, CEO and chairman of Cavallino Consulting, LLC, candidly addresses main issues in the healthcare arena, and offers cures for the operational inefficiencies breaking the current system in his new, accessible guide titled Healthcare, Heal Thyself.
Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
Lianne Deserres, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave Ste 3600s, Hawthorne, NY 10532 Phone: 914-693-7636 | |
Dr. Katrina Ruth Stidham, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave Ste 3100n, Hawthorne, NY 10532 Phone: 914-693-7636 | |
Dr. Tali Lando, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave Ste 3600s, Hawthorne, NY 10532 Phone: 914-693-7636 | |
Matthew Hyun Kim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave Ste 3600n, Hawthorne, NY 10532 Phone: 914-693-7636 | |
Augustine Moscatello, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave Ste 3600s, Hawthorne, NY 10532 Phone: 914-693-7636 |